Cerebral small vessel disease: A review of clinical, radiological, and histopathological phenotypes

International Journal of Stroke

Volumn 7, Issue 1, 2012, Pages 36-46

  Moran, Chris ^a,b   Phan, Thanh G ^a,b   Srikanth, Velandai K ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b Southern Health   (Australia)

Author keywords

Cerebral small vessel disease; Lacune; Stroke

Indexed keywords

ANTITHROMBOCYTIC AGENT; CILOSTAZOLE; DILAZEP; UNCLASSIFIED DRUG;

AGE; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN RADIOGRAPHY; CADASIL; CARDIOVASCULAR RISK; CEREBRAL SMALL VESSEL DISEASE; CEREBROVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; DISEASE MARKER; HISTOPATHOLOGY; HUMAN; INTRACRANIAL HYPERTENSION; MORTALITY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STROKE;

CEREBRAL SMALL VESSEL DISEASES; HUMANS; PHENOTYPE;

EID: 84155192562     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2011.00725.x     Document Type: Review

References (114)

1. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010; 9:689-701.
2. Fisher CM. Capsular infarcts: the underlying vascular lesions. Arch Neurol 1979; 36:65-73.
3. Fisher CM. The arterial lesions underlying lacunes. Acta Neuropathol 1968; 12:1-15.
4. Fisher CM. Lacunes: small, deep cerebral infarcts. Neurology 1965; 15:774-784.
5. Fisher CM. Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol 1971; 30:536-550.
6. Donnan G, Norrving B, Bamford J, Bogousslavsky J (eds). Subcortical Stroke, 2nd edn. Oxford University Press, New York, 2002.
7. Mead GE, Lewis SC, Wardlaw JM, Dennis MS, Warlow CP. Severe ipsilateral carotid stenosis and middle cerebral artery disease in lacunar ischaemic stroke: innocent bystanders? J Neurol 2002; 249:266-271.
8. Potter G, Doubal F, Jackson C, Sudlow C, Dennis M, Wardlaw J. Associations of clinical stroke misclassification ('clinical-imaging dissociation') in acute ischemic stroke. Cerebrovasc Dis 2010; 29:395-402.
9. Sudlow CL, Warlow CP. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International stroke incidence collaboration. Stroke 1997; 28:491-499.
10. Bamford J, Sandercock P, Jones L, Warlow C. The natural history of lacunar infarction: the Oxfordshire Community Stroke Project. Stroke 1987; 18:545-551.
11. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 2007; 6:611-619.
12. Vermeer SE, Den Heijer T, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2003; 34:392-396.
13. Wardlaw JM. Differing risk factors and outcomes in ischemic stroke subtypes: focus on lacunar stroke. Future Neurol 2011; 6:201-222.
14. Patel B, Markus HS. Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker. Int J Stroke 2011; 6:47-59.
15. Norrving B. 'Silent' cerebral infarcts and microbleeds. Handb Clin Neurol 2009; 93:667-681.
16. Arboix A, Marti-Vilalta JL. Lacunar stroke. Expert Rev Neurother 2009; 9:179-196.
17. Wardlaw JM, Doubal F, Armitage P etal. Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol 2009; 65:194-202.
18. Lammie GA. Hypertensive cerebral small vessel disease and stroke. Brain Pathol 2002; 12:358-370.
19. Rosenblum WI. Fibrinoid necrosis of small brain arteries and arterioles and miliary aneurysms as causes of hypertensive hemorrhage: a critical reappraisal. Acta Neuropathol 2008; 116:361-369.
20. Jackson C, Sudlow C. Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts. Stroke 2005; 36:891-901.
21. Jackson CA, Hutchison A, Dennis MS etal. Differing risk factor profiles of ischemic stroke subtypes: evidence for a distinct lacunar arteriopathy? Stroke 2010; 41:624-629.
22. Das RR, Seshadri S, Beiser AS etal. Prevalence and correlates of silent cerebral infarcts in the Framingham Offspring Study. Stroke 2008; 39:2929-2935.
23. Debette S, Bis JC, Fornage M etal. Genome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE Consortium. Stroke 2010; 41:210-217.
24. Arboix A. Retinal microvasculature in acute lacunar stroke. Lancet Neurol 2009; 8:596-598.
25. Lindley RI, Wang JJ, Wong MC etal. Retinal microvasculature in acute lacunar stroke: a cross-sectional study. Lancet Neurol 2009; 8:628-634.
26. Doubal FN, MacGillivray TJ, Hokke PE, Dhillon B, Dennis MS, Wardlaw JM. Differences in retinal vessels support a distinct vasculopathy causing lacunar stroke. Neurology 2009; 72:1773-1778.
27. Thompson CS, Hakim AM. Living beyond our physiological means: small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis. Stroke 2009; 40:e322-330.
28. Knottnerus IL, Govers-Riemslag JW, Hamulyak K etal. Endothelial activation in lacunar stroke subtypes. Stroke 2010; 41:1617-1622.
29. Wang X, Lam WW, Fan YH, Graham CA, Rainer TH, Wong KS. Topographic patterns of small subcortical infarcts associated with MCA stenosis: a diffusion-weighted MRI study. J Neuroimaging 2006; 16:266-271.
30. Macdonald RL, Kowalczuk A, Johns L. Emboli enter penetrating arteries of monkey brain in relation to their size. Stroke 1995; 26:1247-1250. discussion 1250-1.
31. Seifert T, Enzinger C, Storch MK, Pichler G, Niederkorn K, Fazekas F. Acute small subcortical infarctions on diffusion weighted MRI: clinical presentation and aetiology. J Neurol Neurosurg Psychiatry 2005; 76:1520-1524.
32. Tegeler CH, Shi F, Morgan T. Carotid stenosis in lacunar stroke. Stroke 1991; 22:1124-1128.
33. Tejada J, Diez-Tejedor E, Hernandez-Echebarria L, Balboa O. Does a relationship exist between carotid stenosis and lacunar infarction? Stroke 2003; 34:1404-1409.
34. Donnan GA, Norrving B. Lacunes and lacunar syndromes. Handb Clin Neurol 2009; 93:559-575.
35. Gan R, Sacco RL, Kargman DE, Roberts JK, Boden-Albala B, Gu Q. Testing the validity of the lacunar hypothesis: the Northern Manhattan Stroke Study experience. Neurology 1997; 48:1204-1211.
36. Arboix A, Massons J, Garcia-Eroles L, Targa C, Comes E, Parra O. Clinical predictors of lacunar syndrome not due to lacunar infarction. BMC Neurol 2010; 10:31(1-6).
37. Arboix A, Lopez-Grau M, Casasnovas C, Garcia-Eroles L, Massons J, Balcells M. Clinical study of 39 patients with atypical lacunar syndrome. J Neurol Neurosurg Psychiatry 2006; 77:381-384.
38. Arboix A, Garcia-Eroles L, Massons J, Oliveres M, Targa C. Hemorrhagic lacunar stroke. Cerebrovasc Dis 2000; 10:229-234.
39. Anzalone N, Landi G. Non ischaemic causes of lacunar syndromes: prevalence and clinical findings. J Neurol Neurosurg Psychiatry 1989; 52:1188-1190.
40. Baezner H, Blahak C, Poggesi A etal. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology 2008; 70:935-942.
41. Jokinen H, Gouw AA, Madureira S etal. Incident lacunes influence cognitive decline: the LADIS study. Neurology 2011; 76:1872-1878.
42. Schiffrin EL. Progress in secondary prevention of stroke with PROGRESS. The perindopril protection against recurrent stroke study. Curr Hypertens Rep 2002; 4:39-40.
43. Seshadri S, Wolf PA, Beiser A etal. Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring Study. Neurology 2004; 63:1591-1599.
44. Lavallee PC, Labreuche J, Gongora-Rivera F etal. Placebo-controlled trial of high-dose atorvastatin in patients with severe cerebral small vessel disease. Stroke 2009; 40:1721-1728.
45. Rothwell PM, Warlow CP. Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group. Lancet 1999; 353:2105-2110.
46. Benavente OR, White CL, Pearce L etal. The Secondary Prevention of Small Subcortical Strokes (SPS3) study. Int J Stroke 2011; 6:164-175.
47. Pantoni L, Basile AM, Pracucci G etal. Impact of age-related cerebral white matter changes on the transition to disability - the LADIS study: rationale, design and methodology. Neuroepidemiology 2005; 24:51-62.
48. Shinoda-Tagawa T, Yamasaki Y, Yoshida S etal. A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with type II diabetes. Diabetologia 2002; 45:188-194.
49. Nakamura T, Kawagoe Y, Matsuda T, Ueda Y, Ebihara I, Koide H. Silent cerebral infarction in patients with type 2 diabetic nephropathy. Effects of antiplatelet drug dilazep dihydrochloride. Diabetes Metab Res Rev 2005; 21:39-43.
50. de Leeuw FE, de Groot JC, Achten E etal. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001; 70:9-14.
51. Steingart A, Hachinski VC, Lau C etal. Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Arch Neurol 1987; 44:36-39.
52. Srikanth V, Phan TG, Chen J, Beare R, Stapleton JM, Reutens DC. The location of white matter lesions and gait - a voxel-based study. Ann Neurol 2010; 67:265-269.
53. Enzinger C, Fazekas F, Ropele S, Schmidt R. Progression of cerebral white matter lesions - clinical and radiological considerations. J Neurol Sci 2007; 257:5-10.
54. Godin O, Maillard P, Crivello F etal. Association of white-matter lesions with brain atrophy markers: the three-city Dijon MRI study. Cerebrovasc Dis 2009; 28:177-184.
55. Kruit MC, van Buchem MA, Hofman PA etal. Migraine as a risk factor for subclinical brain lesions. JAMA 2004; 291:427-434.
56. Paternoster L, Chen W, Sudlow CL. Genetic determinants of white matter hyperintensities on brain scans: a systematic assessment of 19 candidate gene polymorphisms in 46 studies in 19000 subjects. Stroke 2009; 40:2020-2026.
57. Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol 1987; 44:21-23.
58. Fazekas F, Ropele S, Enzinger C etal. MTI of white matter hyperintensities. Brain 2005; 128(Pt 12):2926-2932.
59. van Straaten EC, Fazekas F, Rostrup E etal. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke 2006; 37:836-840.
60. O'Sullivan M. Leukoaraiosis. Pract Neurol 2008; 8:26-38.
61. Beare R, Srikanth V, Chen J etal. Development and validation of morphological segmentation of age-related cerebral white matter hyperintensities. Neuroimage 2009; 47:199-203.
62. de Laat KF, van Norden AG, Gons RA etal. Diffusion tensor imaging and gait in elderly persons with cerebral small vessel disease. Stroke 2011; 42:373-379.
63. Bastin ME, Clayden JD, Pattie A, Gerrish IF, Wardlaw JM, Deary IJ. Diffusion tensor and magnetization transfer MRI measurements of periventricular white matter hyperintensities in old age. Neurobiol Aging 2009; 30:125-136.
64. Kang CK, Park CA, Kim KN etal. Non-invasive visualization of basilar artery perforators with 7T MR angiography. J Magn Reson Imaging 2010; 32:544-550.
65. Theysohn JM, Kraff O, Maderwald S etal. 7 tesla MRI of microbleeds and white matter lesions as seen in vascular dementia. J Magn Reson Imaging 2011; 33:782-791.
66. Fazekas F, Kleinert R, Offenbacher H etal. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993; 43:1683-1689.
67. Nag S. Blood-brain barrier permeability using tracers and immunohistochemistry. Methods Mol Med 2003; 89:133-144.
68. Young VG, Halliday GM, Kril JJ. Neuropathologic correlates of white matter hyperintensities. Neurology 2008; 71:804-811.
69. Brown WR, Moody DM, Challa VR, Thore CR, Anstrom JA. Venous collagenosis and arteriolar tortuosity in leukoaraiosis. J Neurol Sci 2002; 203-4:159-163.
70. Simpson JE, Hosny O, Wharton SB etal. Microarray RNA expression analysis of cerebral white matter lesions reveals changes in multiple functional pathways. Stroke 2009; 40:369-375.
71. Teodorczuk A, O'Brien JT, Firbank MJ etal. White matter changes and late-life depressive symptoms: longitudinal study. Br J Psychiatry 2007; 191:212-217.
72. Srikanth V, Beare R, Blizzard L etal. Cerebral white matter lesions, gait, and the risk of incident falls: a prospective population-based study. Stroke 2009; 40:175-180.
73. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010; 341:c3666.
74. Dufouil C, Chalmers J, Coskun O etal. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 2005; 112:1644-1650.
75. Mok VC, Lam WW, Fan YH, Wong A. Effects of statins on the progression of cerebral white matter lesion, post hoc analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study. J Neurol 2009; 256:750-757.
76. Flaherty ML, Woo D, Haverbusch M etal. Racial variations in location and risk of intracerebral hemorrhage. Stroke 2005; 36:934-937.
77. Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol 2006; 5:53-63.
78. Broderick J, Connolly S, Feldmann E etal. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007; 38:2001-2023.
79. Tanaka A, Ueno Y, Nakayama Y, Takano K, Takebayashi S. Small chronic hemorrhages and ischemic lesions in association with spontaneous intracerebral hematomas. Stroke 1999; 30:1637-1642.
80. Rost NS, Rahman RM, Biffi A etal. White matter hyperintensity volume is increased in small vessel stroke subtypes. Neurology 2010; 75:1670-1677.
81. Fisher CM. Hypertensive cerebral hemorrhage. Demonstration of the source of bleeding. J Neuropathol Exp Neurol 2003; 62:104-107.
82. Rosenblum WI. Cerebral hemorrhage produced by ruptured dissecting aneurysm in miliary aneurysm. Ann Neurol 2003; 54:376-378.
83. Mori E, Tabuchi M, Yamadori A. Lacunar syndrome due to intracerebral hemorrhage. Stroke 1985; 16:454-459.
84. Greenberg SM, Vernooij MW, Cordonnier C etal. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009; 8:165-174.
85. Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 2007; 130(Pt 8):1988-2003.
86. Vernooij MW, van der Lugt A, Ikram MA etal. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology 2008; 70:1208-1214.
87. Schrag M, McAuley G, Pomakian J etal. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol 2010; 119:291-302.
88. Grinberg LT, Thal DR. Vascular pathology in the aged human brain. Acta Neuropathol 2010; 119:277-290.
89. Lee SH, Bae HJ, Kwon SJ etal. Cerebral microbleeds are regionally associated with intracerebral hemorrhage. Neurology 2004; 62:72-76.
90. Werring DJ, Frazer DW, Coward LJ etal. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain 2004; 127(Pt 10):2265-2275.
91. Viswanathan A, Godin O, Jouvent E etal. Impact of MRI markers in subcortical vascular dementia: a multi-modal analysis in CADASIL. Neurobiol Aging 2008; 31:1629-1636.
92. Doubal FN, MacLullich AM, Ferguson KJ, Dennis MS, Wardlaw JM. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke 2010; 41:450-454.
93. Zhu YC, Dufouil C, Mazoyer B etal. Frequency and location of dilated Virchow-Robin spaces in elderly people: a population-based 3D MR imaging study. AJNR Am J Neuroradiol 2011; 32:709-713.
94. Gouw AA, Seewann A, van der Flier WM etal. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 2011; 82:126-135.
95. Tournier-Lasserve E, Iba-Zizen MT, Romero N, Bousser MG. Autosomal dominant syndrome with strokelike episodes and leukoencephalopathy. Stroke 1991; 22:1297-1302.
96. Opherk C, Peters N, Herzog J, Luedtke R, Dichgans M. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain 2004; 127(Pt 11):2533-2539.
97. Yamamoto Y, Craggs L, Baumann M, Kalimo H, Kalaria RN. Review: molecular genetics and pathology of hereditary small vessel diseases of the brain. Neuropathol Appl Neurobiol 2011; 37:94-113.
98. Chabriat H, Bousser MG. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Handb Clin Neurol 2008; 89:671-686.
99. Chabriat H, Vahedi K, Iba-Zizen MT etal. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet 1995; 346:934-939.
100. Mykkanen K, Junna M, Amberla K etal. Different clinical phenotypes in monozygotic CADASIL twins with a novel NOTCH3 mutation. Stroke 2009; 40:2215-2218.
101. Yamamoto Y, Ihara M, Tham C etal. Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL. Stroke 2009; 40:2004-2011.
102. Jacqmin M, Herve D, Viswanathan A etal. Confluent thalamic hyperintensities in CADASIL. Cerebrovasc Dis 2010; 30:308-313.
103. Peters N, Holtmannspotter M, Opherk C etal. Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease. Neurology 2006; 66:1517-1522.
104. Dichgans M, Holtmannspotter M, Herzog J, Peters N, Bergmann M, Yousry TA. Cerebral microbleeds in CADASIL: a gradient-echo magnetic resonance imaging and autopsy study. Stroke 2002; 33:67-71.
105. Kalimo H, Ruchoux MM, Viitanen M, Kalaria RN. CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol 2002; 12:371-384.
106. Miao Q, Paloneva T, Tuisku S etal. Arterioles of the lenticular nucleus in CADASIL. Stroke 2006; 37:2242-2247.
107. Gray F, Robert F, Labrecque R etal. Autosomal dominant arteriopathic leuko-encephalopathy and Alzheimer's disease. Neuropathol Appl Neurobiol 1994; 20:22-30.
108. Santa Y, Uyama E, Chui DH etal. Genetic, clinical and pathological studies of CADASIL in Japan: a partial contribution of Notch3 mutations and implications of smooth muscle cell degeneration for the pathogenesis. J Neurol Sci 2003; 212:79-84.
109. del Rio-Espinola A, Mendioroz M, Domingues-Montanari S etal. CADASIL management or what to do when there is little one can do. Expert Rev Neurother 2009; 9:197-210.
110. Robinson W, Galetta SL, McCluskey L, Forman MS, Balcer LJ. Retinal findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (cadasil). Surv Ophthalmol 2001; 45:445-448.
111. Buffon F, Porcher R, Hernandez K etal. Cognitive profile in CADASIL. J Neurol Neurosurg Psychiatry 2006; 77:175-180.
112. Epelbaum S, Benisty S, Reyes S etal. Verbal memory impairment in subcortical ischemic vascular disease A descriptive analysis in CADASIL. Neurobiol Aging 2011; 32:2172-2182.
113. Liem MK, Lesnik Oberstein SA, Haan J etal. MRI correlates of cognitive decline in CADASIL: a 7-year follow-up study. Neurology 2009; 72:143-148.
114. Dichgans M, Markus HS, Salloway S etal. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. Lancet Neurol 2008; 7:310-318.